Kura Oncology: UBS Maintains Buy, PT Down to $15 from $16.

Friday, Mar 13, 2026 4:31 pm ET1min read
KURA--

Kura Oncology: UBS Maintains Buy, PT Down to $15 from $16.

Kura Oncology: UBS Maintains Buy, PT Down to $15 from $16.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet